Insulet expands Omnipod 5 to four more International markets

Insulet (PODD) announced its revolutionary Omnipod 5 Automated Insulin Delivery System is now available in Australia and will soon be offered in three additional countries, helping transform the lives of thousands more people with diabetes around the world. Omnipod 5 is now commercially available in Australia with Dexcom (DXCM) G6 and G7 compatibility, with plans underway to soon add Abbott’s (ABT) FreeStyle Libre 2 Plus. Omnipod 5 will be accessible in Belgium in the coming weeks, with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 and G7 sensor integrations. Omnipod 5 will next launch in Canada later this spring with Dexcom G6 and G7 compatibility. Omnipod 5 will also be offered in Switzerland, also later this spring, with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 and G7 sensor integrations. Insulet also recently expanded sensor integrations to include Dexcom G7 for Omnipod 5 users in the U.K. and the Netherlands. Additionally, Insulet is planning to bring Omnipod 5 to five more markets including Israel, Saudi Arabia, the United Arab Emirates, Qatar, and Kuwait. Timing will be shared in the coming months.